Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity.

Brkljacic, Jelena; Pauk, Martina; Erjavec, Igor; Cipcic, Antonio; Grgurevic, Lovorka; Zadro, Renata; Inman, Gareth J; Vukicevic, Slobodan

Brkljacic, Jelena; Pauk, Martina; Erjavec, Igor; Cipcic, Antonio; Grgurevic, Lovorka; Zadro, Renata; Inman, Gareth J; Vukicevic, Slobodan.

Affiliation

Brkljacic J; Laboratory for Mineralized Tissues, Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Salata 11, 10000, Zagreb, Croatia. jelena.brkljacic@mef.hr

Int Orthop ; 37(3): 529-41, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23307015

Subject(s)

Anticoagulants/pharmacology; Bone Morphogenetic Protein 6/metabolism; Heparin/pharmacology; Osteogenesis/drug effects; Animals; Bone Morphogenetic Protein 6/antagonists & inhibitors; Cell Line; Disease Models, Animal; Mice; Osteoporosis/physiopathology; Rats; Rats, Sprague-Dawley

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Heparin / Bone Morphogenetic Protein 6 / Anticoagulants Limits: Animals Language: En Journal: Int Orthop Year: 2013 Type: Article Affiliation country: Croatia

Fulltext

XML

PubMed Links

Search on Google